Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Evaluation of MAGE A1 in oral squamous cell carcinoma.

Pereira CM, Gomes CC, De Fátima Correia Silva J, Bucciarelli Rodriguez M, Barbosa AA, Gomez RS.

Oncol Rep. 2012 Jun;27(6):1843-8. doi: 10.3892/or.2012.1736. Epub 2012 Mar 19.

PMID:
22447174
2.

Expression of melanoma-associated antigens in oral squamous cell carcinoma.

Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E.

J Oral Pathol Med. 2008 Feb;37(2):88-93. doi: 10.1111/j.1600-0714.2007.00600.x.

PMID:
18197853
3.

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.

Oncol Rep. 2009 Nov;22(5):1173-9.

PMID:
19787237
4.

Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report.

Mollaoglu N, Metzler P, Zenk J, Nkenke E, Neukam FW, Ries J.

Cytopathology. 2011 Dec;22(6):387-91. doi: 10.1111/j.1365-2303.2010.00814.x. Epub 2010 Nov 4.

PMID:
21054590
6.

Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.

Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK, Mao L.

Cancer Res. 2001 Nov 1;61(21):7959-63.

7.

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM.

Br J Cancer. 2006 Feb 27;94(4):561-8.

8.

Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.

Ries J, Agaimy A, Vairaktaris E, Kwon Y, Neukam FW, Strassburg LH, Nkenke E.

Int J Oncol. 2012 Sep;41(3):1085-93. doi: 10.3892/ijo.2012.1532. Epub 2012 Jun 26.

PMID:
22751922
9.

Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.

Xiao J, Chen HS, Fei R, Cong X, Wang LP, Wang Y, Jiang D, Wei L, Wang Y.

J Gastroenterol. 2005 Jul;40(7):716-21.

PMID:
16082588
10.

Expression of MAGE-A12 in oral squamous cell carcinoma.

Mollaoglu N, Vairaktaris E, Nkenke E, Neukam FW, Ries J.

Dis Markers. 2008;24(1):27-32.

11.

Detection of MAGE-A expression predicts malignant transformation of oral leukoplakia.

Ries J, Agaimy A, Vairaktaris E, Gorecki P, Neukam FW, Strassburg LH, Nkenke E.

Cancer Invest. 2012 Aug;30(7):495-502. doi: 10.3109/07357907.2012.691191. Epub 2012 May 31.

PMID:
22646284
12.

5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.

Qiu G, Fang J, He Y.

Clin Biochem. 2006 Mar;39(3):259-66. Epub 2006 Mar 6.

PMID:
16516880
13.

The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies.

Suyama T, Ohashi H, Nagai H, Hatano S, Asano H, Murate T, Saito H, Kinoshita T.

Leuk Res. 2002 Dec;26(12):1113-8.

PMID:
12443884
14.

Demethylation of MAGE promoters during gastric cancer progression.

Honda T, Tamura G, Waki T, Kawata S, Terashima M, Nishizuka S, Motoyama T.

Br J Cancer. 2004 Feb 23;90(4):838-43.

15.

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.

Cancer Res. 2002 Jul 15;62(14):3971-9.

16.

Characterization of melanoma-associated antigen-a genes family differential expression in non-small-cell lung cancers.

Karimi S, Mohammadi F, Porabdollah M, Mohajerani SA, Khodadad K, Nadji SA.

Clin Lung Cancer. 2012 May;13(3):214-9. doi: 10.1016/j.cllc.2011.09.007. Epub 2011 Dec 3.

PMID:
22138038
17.

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.

De Smet C, Lurquin C, Lethé B, Martelange V, Boon T.

Mol Cell Biol. 1999 Nov;19(11):7327-35.

18.

Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma.

Kordi-Tamandani DM, Moazeni-Roodi A, Rigi Ladez MA, Hashemi M, Birjandian E, Torkamanzehi A.

Int J Biol Markers. 2010 Apr-Jun;25(2):99-103.

PMID:
20586029
19.

Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.

Kordi-Tamandani DM, Moazeni-Roodi AK, Rigi-Ladiz MA, Hashemi M, Birjandian E, Torkamanzehi A.

Arch Oral Biol. 2010 Oct;55(10):809-14. doi: 10.1016/j.archoralbio.2010.06.017. Epub 2010 Aug 1.

PMID:
20674887
20.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

Items per page

Supplemental Content

Write to the Help Desk